(Press-News.org) The ACMG Foundation for Genetic and Genomic Medicine is proud to present the ACMG Foundation/David L. Rimoin Inspiring Excellence Award to Isabelle B. Cooperstein, BS for her featured platform presentation at the 2023 ACMG Annual Clinical Genetics Meeting, “Discovery and therapeutic implications of pathogenic retroelements in neurodegenerative diseases.”
Isabelle B. Cooperstein, BS, is a third-year PhD candidate in the Department of Human Genetics at the University of Utah in Salt Lake City. She obtained a Bachelor of Science in Molecular Biology with a minor in Mathematics from the University of Wisconsin-Madison in 2017. She was awarded the Hilldale Undergraduate Research Fellowship to complete a senior honors thesis with Dr. Gregory Gauthier to study the mechanisms used by fungi to adapt to temperature. Since joining the lab of Dr. Gabor Marth in 2021, her research interests have shifted to developing software tools for use in the diagnostic process of rare disease patients. Her work focuses on combining the properties of the Human Phenotype Ontology with sequencing data to create a visual and interactive representation of the similarity between patients in the Undiagnosed Disease Network. The long-term goal of this research is to create a tool that aids in providing disease solutions without requiring high-level programming or command-line skills, making it accessible to any member of the clinical team.
“Helping the next generation of genetics professionals find their places in our field was a passion and mission for Dr. Rimoin. We are pleased to recognize Isabelle Cooperstein, a graduate student at University of Utah, as this year’s David L. Rimoin Inspiring Excellence Award,” said Bruce R. Korf, MD, PhD, FACMG, president of the ACMG Foundation for Genetic and Genomic Medicine.
The David L. Rimoin Inspiring Excellence Award was created in memory of the late Dr. David L. Rimoin, one of the founders of the American College of Medical Genetics and Genomics (ACMG) who died in 2012. Dr. Rimoin touched the lives of generations of patients as well as trainees and colleagues. The award is a cash award given to a selected student, trainee or junior faculty ACMG member whose abstract submission was chosen for a platform presentation to be given at the ACMG Annual Clinical Genetics Meeting.
“I am thrilled and honored to have been selected to receive the David L. Rimoin Inspiring Excellence Award. I am extremely grateful to the participating families in the Undiagnosed Disease Network as well as those who helped form this collaboration. I would also like to thank Drs. Gabor Marth and Alistair Ward for mentoring my PhD work and supporting me along this path. I hope that our work will be a valuable addition to the diagnostic process and further encourage the collaboration of clinicians, researchers and families with its accessibility,” said Ms. Cooperstein.
Dr. Ann Garber-Rimoin, Dr. Rimoin’s widow, said, “The Rimoin Family is excited to honor Ms. Cooperstein with the Inspiring Excellence Award to recognize her visionary work on combining software and diagnostic criteria to further advance progress in both the Undiagnosed Disease Network and the Global Alliance for Genomics and Health. Her work provides a path towards a greater understanding of patients who lack a clear diagnosis for the patients themselves, their families, and clinicians.”
About the ACMG Foundation for Genetic and Genomic Medicine
The ACMG Foundation for Genetic and Genomic Medicine, a 501(c)(3) nonprofit organization, is a community of supporters and contributors who understand the importance of medical genetics and genomics in healthcare. Established in 1992, the ACMG Foundation supports the American College of Medical Genetics and Genomics (ACMG) mission to “translate genes into health.” Through its work, the ACMG Foundation fosters charitable giving, promotes training opportunities to attract future medical geneticists and genetic counselors to the field, shares information about medical genetics and genomics, and sponsors important research. To learn more and support the ACMG Foundation mission to create “Better Health through Genetics” visit acmgfoundation.org.
Note to editors: To arrange interviews with experts in medical genetics, contact ACMG Senior Director of Communications and Public Relations Kathy Moran, MBA at firstname.lastname@example.org.
Isabelle B. Cooperstein is the recipient of the 2023 ACMG Foundation/David L. Rimoin Inspiring Excellence Award
ELSE PRESS RELEASES FROM THIS DATE:
Study compares NGO communication around migration
AMES, IA – Since 1970, the number of people living outside their countries of birth has tripled. Most migrants are looking for work or better economic opportunities. But millions seek to escape violence, persecution or natural disasters. Their integration into a new society often depends on non-governmental organizations that provide services and advocate on their behalf. A recently published study highlights how the specific political and cultural context of a country affects the NGOs’ communication with the public. Co-author and Iowa State Professor Daniela Dimitrova specializes in international journalism and global media coverage. ...
Nara Sobreira, MD, PhD is the recipient of the 2023 Dr. Michael S. Watson Genetic and Genomic Medicine Innovation Award from the ACMG Foundation for Genetic and Genomic Medicine
Nara Lygia de Macena Sobreira, MD, PhD is the recipient of the ACMG Foundation for Genetic and Genomic Medicine’s 2023 Dr. Michael S. Watson Genetic and Genomic Medicine Innovation Award—the “Watson Award”—named for the American College of Medical Genetics and Genomics first and longstanding executive director, Michael S. Watson, MS, PhD, FACMG. “I am honored and grateful for receiving the 2023 Dr. Michael S. Watson Genetic and Genomic Medicine Innovation Award. Since the beginning of my medical genetics residency in Brazil, I have been blessed to work with amazing mentors and colleagues in innovative ...
Hearing aids donated to Ukrainian refugees in response to article published in The Hearing Journal
March 15, 2023 – In response to an article published in the February issue of The Hearing Journal, the audiology and hearing solutions company ReSound donated nearly 120 rechargeable hearing aids to address the hearing health care crisis among Ukrainian refugees in Poland. The Hearing Journal is published in the Lippincott portfolio by Wolters Kluwer. The hearing aids were given to the Heart of Hearing team, which is led by King Chung, PhD, CCC-A, professor of audiology at Northern Illinois University in DeKalb, IL and the director of the audiology ...
Comparison with Canada highlights poor access to US methadone treatment
SPOKANE, Wash.—People living in the United States must travel significantly farther to access methadone treatment for opioid addiction than Canadians, suggests a new study led by Washington State University researchers. Published in the journal Drug and Alcohol Dependence, the researchers’ analysis showed that the average driving distance to the closest methadone clinic accepting new patients was more than three times greater in the U.S. compared to Canada. When limiting their analysis to clinics that could provide treatment within 48 hours the difference was even larger, with those in the U.S. having to travel more than five times farther than their ...
The war on sugar: How can soda manufacturers reduce sugar in products without endangering sales?
Researchers from University of North Carolina at Chapel Hill and University of Amsterdam published a new Journal of Marketing study that examines how sugar reduction strategies affect new product sales. The study, forthcoming in the Journal of Marketing, is titled “A War on Sugar? Effects of Reduced Sugar Content and Package Size in The Soda Category” and is authored by Kristopher O. Keller and Jonne Y. Guyt. The United States has a sugar problem. Excessive ...
Alexander M. Holtz, MD, PhD receives the 2023 Richard King Award for Best Publication by a Trainee in Genetics in Medicine
Alexander M. Holtz, MD, PhD is the recipient of the 2023 Richard King Trainee Award. This award was instituted by the ACMG Foundation for Genetic and Genomic Medicine to encourage American Board of Medical Genetics and Genomics (ABMGG), international equivalents, or genetic counseling trainees in their careers and to foster the publication of the highest quality research in Genetics in Medicine (GIM), an official journal of the ACMG. Each year the editorial board reviews all articles published in GIM by eligible trainees ...
Sarah Jurgensmeyer, MS, CGC receives the 2023 ACMG Foundation Carolyn Mills Lovell Genetic Counselor Award
Sarah Jurgensmeyer, MS, CGC is the recipient of the 2023 ACMG Foundation Carolyn Mills Lovell Genetic Counselor Award. Ms. Jurgensmeyer received the Lovell award for her platform presentation at the 2023 ACMG Annual Clinical Genetics Meeting, “Genetic Counselor-Led Exome Sequencing Clinic Pilot Program to Increase Access to Pediatric Genetic Services.” ACMG Foundation President Bruce R. Korf, MD, PhD, FACMG said, “Congratulations to Sarah Jurgensmeyer, recipient of this year’s ACMG ...
ATS 2023 Conference Program is live! Register now
WHAT: ATS 2023 Conference Program is Live! Register Now WHO: Scientific Sessions in Pulmonary, Critical Care and Sleep Medicine WHERE: Walter E. Washington Convention Center, Washington, DC WHEN: May 21-24* The ATS 2023 International Conference Program is now live! Get ready for a series of dynamic scientific ...
New study from Japan shows SARS-CoV-2 Omicron XBB.1.5 variant is highly transmissible and infectious
COVID-19 has caused significant global panic after its rapid emergence more than 3 years ago. Although we now have highly effective vaccines against the SARS-CoV-2 virus, which causes COVID-19, scientists continue to study emerging SARS-CoV-2 variants in order to safeguard public health and devise global preventive strategies against emerging variants. A team led by Japanese researchers has recently discovered that the SARS-CoV-2 Omicron XBB.1.5 variant, prevalent in the Western hemisphere, has high transmissibility and infectivity. Severe acute respiratory ...
Immune cell gives possible explanation for sex differences in pancreatic cancer
Immunotherapy is an effective form of therapy for different types of cancer. However, for pancreatic cancer, its effect is limited and differs between men and women. Researchers at Karolinska Institutet have now found a possible explanation for this sex difference. The study, which is published in Cancer Research, reveals the presence of an immune cell in women with pancreatic cancer that obstructs the body’s immune response. The results can pave the way for a more sex-specific treatment. “More and more evidence is coming in that male and female hormones affect ...